lucanthone has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, P; Chowdhury, SM; Lee, S; Naidu, M; Peña, LA; Sanchez, Z; Sitharaman, B; Suresh Kumar, MA; Surhland, C; Waring, M | 1 |
| Fung, H; Mason, JM; Naidu, MD; Peña, LA; Pica, RV | 1 |
| Bases, R; Bello, J; Del Rowe, JD; Filippi, C; Freeman, K; Mendez, F; Mitnick, R; Moran, J; Sood, B | 1 |
3 other study(ies) available for lucanthone and Brain Neoplasms
| Article | Year |
|---|---|
Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Coculture Techniques; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Delivery Systems; Flow Cytometry; Glioblastoma; Graphite; Humans; Hydrogen-Ion Concentration; Lucanthone; Mice; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasm Transplantation; Neuroglia; Oxygen; Rats; Stem Cells | 2015 |
Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1.
Topics: Base Sequence; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Damage; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Gene Expression; Glioma; Humans; Indoles; Lucanthone; Radiation Tolerance; RNA, Small Interfering | 2010 |
Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Enzyme Inhibitors; Female; Humans; Lucanthone; Male; Mice; Mice, Inbred C3H; Rats; Rats, Sprague-Dawley; Topoisomerase II Inhibitors | 1999 |